Famotidine
Famotidine is a pharmaceutical drug with 82 clinical trials. Currently 9 active trials ongoing. Historical success rate of 84.8%.
Success Metrics
Based on 56 completed trials
Phase Distribution
Phase Distribution
43
Early Stage
19
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.4%
56 of 68 finished
17.6%
12 ended early
9
trials recruiting
82
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Gastrointestinal Dysmotility on Aspiration Risk
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Clinical Trials (82)
Gastrointestinal Dysmotility on Aspiration Risk
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia
Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 82